These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 8009701)

  • 1. [Hyperuricemia].
    Slot O
    Ugeskr Laeger; 1994 Apr; 156(16):2396-401. PubMed ID: 8009701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary nephropathy associated with hyperuricemia and gout.
    Puig JG; Miranda ME; Mateos FA; Picazo ML; Jiménez ML; Calvin TS; Gil AA
    Arch Intern Med; 1993 Feb; 153(3):357-65. PubMed ID: 8427538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic value of renal urate excretion].
    Häntzschel U; Költzsch V
    Z Gesamte Inn Med; 1978 Mar; 33(6):180-4. PubMed ID: 645153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical aspects of monosodium urate monohydrate crystal deposition disease (gout).
    Becker MA
    Rheum Dis Clin North Am; 1988 Aug; 14(2):377-94. PubMed ID: 3051156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis, clinical findings and management of acute and chronic gout.
    Corrado A; D'Onofrio F; Santoro N; Melillo N; Cantatore FP
    Minerva Med; 2006 Dec; 97(6):495-509. PubMed ID: 17213786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precocious familial gout with reduced fractional urate clearance and normal purine enzymes.
    Calabrese G; Simmonds HA; Cameron JS; Davies PM
    Q J Med; 1990 May; 75(277):441-50. PubMed ID: 2388995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of control and self-medication of chronic gout in a developing country. Outcome after 10 years.
    Darmawan J; Rasker JJ; Nuralim H
    J Rheumatol; 2003 Nov; 30(11):2437-43. PubMed ID: 14677190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention and therapy of disorders of purine metabolism].
    Schröder HE; Thiele P; Heidelmann G
    Z Gesamte Inn Med; 1982 Jul; 37(13):431-6. PubMed ID: 7136086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperuricaemia: more than just a cause of gout?
    Katsiki N; Karagiannis A; Athyros VG; Mikhailidis DP
    J Cardiovasc Med (Hagerstown); 2013 Jun; 14(6):397-402. PubMed ID: 23032963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathogenesis, diagnostics and therapy of gout].
    Zurek M
    Vnitr Lek; 2006; 52(7-8):736-41. PubMed ID: 16967617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does asymptomatic hyperuricaemia contribute to the development of renal and cardiovascular disease? An old controversy renewed.
    Kanellis J; Feig DI; Johnson RJ
    Nephrology (Carlton); 2004 Dec; 9(6):394-9. PubMed ID: 15663643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gouty nephropathy (a review of the literature)].
    Siniachenko OV; Diadyk AI; Vasilenko IV
    Vrach Delo; 1984 Jul; (7):96-100. PubMed ID: 6475032
    [No Abstract]   [Full Text] [Related]  

  • 13. [Evaluation of hyperuricemia caused by fructose in a status of altered uric acid metabolism].
    Menghini S; Della Corte E
    Quad Sclavo Diagn; 1987 Dec; 23(4):441-6. PubMed ID: 3509875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy of hyperuricemia and gout].
    Pöllmann G; Kullich W; Klein G
    Wien Med Wochenschr; 1997; 147(16):382-7. PubMed ID: 9446417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [How to treat hyperuricemia?].
    Favre H
    Schweiz Med Wochenschr; 1984 Sep; 114(37):1269-71. PubMed ID: 6484556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hyperuricemia: explain, ignore or treat?].
    Kummer H
    Schweiz Med Wochenschr; 1986 Jun; 116(24):797-801. PubMed ID: 3726511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights into the epidemiology of gout.
    Doherty M
    Rheumatology (Oxford); 2009 May; 48 Suppl 2():ii2-ii8. PubMed ID: 19447779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Calcium antagonists: current and future applications based on new evidence. The mechanisms on lowering serum uric acid level by calcium channel blockers].
    Mizuta E; Hamada T; Igawa O; Shigemasa C; Hisatome I
    Clin Calcium; 2010 Jan; 20(1):45-50. PubMed ID: 20048433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of hyperuricaemia and gout.
    Masseoud D; Rott K; Liu-Bryan R; Agudelo C
    Curr Pharm Des; 2005; 11(32):4117-24. PubMed ID: 16375732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gout, uric acid and renal disease.
    Emmerson BT
    Med J Aust; 1976 Mar; 1(12):403-5. PubMed ID: 1272125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.